| Literature DB >> 26696832 |
Abstract
In the last few decades, knowledge about astrocytic functions has significantly increased. It was demonstrated that astrocytes are not passive elements of the central nervous system (CNS), but active partners of neurons. There is a growing body of knowledge about the calcium excitability of astrocytes, the actions of different gliotransmitters and their release mechanisms, as well as the participation of astrocytes in the regulation of synaptic functions and their contribution to synaptic plasticity. However, astrocytic functions are even more complex than being a partner of the "tripartite synapse," as they can influence extrasynaptic neuronal currents either by releasing substances or regulating ambient neurotransmitter levels. Several types of currents or changes of membrane potential with different kinetics and via different mechanisms can be elicited by astrocytic activity. Astrocyte-dependent phasic or tonic, inward or outward currents were described in several brain areas. Such currents, together with the synaptic actions of astrocytes, can contribute to neuromodulatory mechanisms, neurosensory and -secretory processes, cortical oscillatory activity, memory, and learning or overall neuronal excitability. This mini-review is an attempt to give a brief summary of astrocyte-dependent extrasynaptic neuronal currents and their possible functional significance.Entities:
Keywords: astrocyte-neuron interactions; gliotransmitters; slow inward current; slow outward current; tonic current
Year: 2015 PMID: 26696832 PMCID: PMC4673305 DOI: 10.3389/fncel.2015.00474
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 5.505
Figure 1Summary of the astrocytic actions on neuronal extrasynaptic currents. (A) Slow inward current (SIC). (1) Astrocytes can be activated by purinoreceptors (e.g., P2X7), metabotropic glutamate receptors (mGluRs), other metabotropic receptors or channelrhodopsin-2 (ChR2) expressed in an astrocyte-specific way. (2) Glutamate (and D-serine) is released by astrocytes. Besides exocytosis of vesicles containing gliotransmitters, the reverse mode of glutamate transporters EAAT-1 and -2, organic anion transporters, volume-regulated anion channels (VRAC), connexon hemichannels, ionotropic purinergic receptors, or blockade of glutamate transporters are the molecules responsible for glutamate release. (3) Glutamate (and D-serine) diffuses to a neuron close to the release site and binds to extrasynaptic NMDA receptors. The activation of these receptors leads to SICs. Note that blockade of neuronal EAAT-2 can also contribute to the elevation of ambient glutamate levels eliciting SICs. (B) Tonic excitatory current. (4) Astrocytic activation via purinoreceptors (e.g., P2X7), mGluRs, other metabotropic receptors or channelrhodopsin-2 (see 1). (5) Release of glutamate and co-activators like D-serine (see 2). (6) Glutamate spillover from synaptic clefts (and volume transmission) also increases extrasynaptic glutamate concentration. (7) Diffusion of glutamate leading to SICs in a location closer to its release site can elicit tonic inward current. (8) Activation of extrasynaptic NMDA receptors, AMPA receptors and extrasynaptic mGluRs (9) lead to tonic excitatory currents. (C) Tonic inhibitory current. (10) Glutamate acting on a different set of mGluRs can elicit outward currents. (11) Activation of astrocytes by different receptors. Although astrocytes activated by ChR2 can potentially generate outward currents on certain neurons, it has not been directly shown. (12) GABA is released by GABA transporters in reverse mode (or by inhibition of the normal mode), VRACs or organic anion transporters. ATP is released via connexon hemichannels. (13) Increase of ambient glutamate concentration facilitates glutamate uptake and GABA release. (14) GABA released by astrocytes or resulted from volume transmission or spillover from synapses, activates extrasynaptic GABA receptors. (15) ATP activates P2X4 receptor which downregulates the number of GABA receptors, thus decreases the amplitude of tonic outward current. (D) Slow outward currents (SOCs). (16) Astrocytic activation (see 11). (17) Release of GABA and ATP/adenosine (see 12). (18) SOCs are generated by activation of extrasynaptic GABAA receptors. (19) SOC-like hyperpolarizing events can be seen by activation of A1 adenosine receptor. Adenosine stimulating these receptors likely has non-neuronal origin. A scheme of an excitatory synapse can be seen between panels A and B, whereas an inhibitory synapse is shown between panels C and D.
Phasic excitatory and inhibitory currents of different brain areas.
| Nucleus accumbens | D'Ascenso et al., | 120.5 ± 9.3 | 0.05–0.2 | 81.4 ± 5.8 | 451 ± 42.2 | DHPG, ATP, baclofen, low Ca2+ ACSF, uncaging Ca2+ | D-AP5, ifenprodil | Yes | Stimulation of glutamatergic afferent; 10 trains with 30 Hz, repeated with 1 s intervals; MPEP prevented frequency increase elicited by stimulation |
| Olfactory bulb, granule cell | Kozlov et al., | Approx. 30–100 | 0.24 ± 0.1 | MK-801 | |||||
| Ventrobasal thalamus | Pirttimaki et al., | 124.7 ± 0.5 | 0.07 ± 0.01 | 117.2 ± 20.8 | 831.4 ± 336.8 | t-ACPD | D-AP5, ifenprodil | Lemniscal or cortical inputs; 10–20 stimuli with 50 Hz in every 5–10 s for 60–120 s. The frequency increase is prevented by group I. mGluR antagonists, and the effect remained for at least further 1 h. | |
| Medial nucleus of the trapezoid body | Reyes-Haro et al., | 89.3 ± 9.7 | 0.275 ± 0.056 | 166.6 ± 16.3 | Strychnine, gabazine, TTX after astrocyte stimulation | BAPTA dialysis of astrocytes, ifenprodil, MK-801+APV, DAAO | Rarely | Local electrical stimulation (amplitude of SICs increased) | |
| Primary visual cortex | Chen et al., | Approx. 26 and 15 pA | 3.2 ± 1.1 | 13.08; 18.64 ± 2.31 | 116.47; 46.04 ± 3.42 | Acetylcholine, photostimulation of ChR2-expressing astrocytes | BAPTA perfusion of astrocytes, D-AP5 | ||
| Hippocampus | Fellin et al., | 95 ± 36.7 | 0.16 ± 0.04 | 92.3 ± 29 | 538.5 ± 176 | DHPG, uncaging Ca2+ | D-AP5, ifenprodil, MK-801, 1 mM Mg2+ | Yes | Stimulation of Schaffer collateral (100–200 ms long trains with 25–30 Hz frequency, 0.3–1 Hz repetition frequency) |
| Angulo et al., | 104 ± 13 | 0.82 ± 0.15 | 135.5 ± 20 | 608.2 ± 216.45 | DHPG, PGE2 | D-AP5, MK-801 | Yes | ||
| Perea and Araque, | 18.3 ± 1.4 (spontaneous); 77.7 ± 1.3 (evoked) | 0.79 ± 0.09 | 13.9 ± 1.7 | 72.5 ± 11.1 | D-AP-5, 2 mM Mg2+
| Stimulation of Schaffer collateral | |||
| Shigetomi et al., | 29 ± 1 | 0.03 ± 0.005 | 46 ± 18 | 196 ± 92 | thrombin, TFLLR-NH2 | BAPTA or fluoroacetate incubation, ifenprodil, D-AP5 | |||
| Spinal cord | Nie et al., | 477 ± 43.42 | 0.04 ± 0.003 | 332.46 ± 31.46 | 1630.61 ± 153.87 | TBOA | TTX + TBOA; fluorocitrate + TBOA; D-AP5; Ro 25-6981 (amplitude reduction) | Stimulation of spinal dorsal root entry zone, in the presence of TBOA | |
| Bardoni et al., | 80.3 ± 12.8 | 0.01 ± 0.01 (12.5% of all tested neurons displayed SICs) | 83.5 ± 16.1 | 423.1 ± 65.9 | BzATP, low Ca2+ | Peripherial inflammation (by intraplantar zymosan injection) | |||
| Thalamic nuclei (dorsal lateral geniculate nucleus, nucleus reticularis thalami, ventrobasal complex) | Jiménez-González et al., | 111.3 ± 31.27 | 0.02 ± 0.01 | 108.9 ± 34.53 | Hypo-osmotic stimulus, vigabatrin | Gabazine (SR95531) | |||
| Olfactory bulb, mitral cell | Kozlov et al., | 266 ± 26 | 0.95 ± 0.16 | 47.2 ± 4.2 | 350 ± 25 | Calcium-free ACSF, hypo-osmotic stimulus | Gabazine (SR95531), picrotoxin, bicuculline (partial) | Yes | Mechanical stimulation of astrocytes or blood vessels |
| Hippocampus | Le Meur et al., | 71.05 ± 14.99 (CA3) 46.95 ± 6.93 (DG) | 0.04 ± 0.02 (CA1) 0.15 ± 0.04 (CA3) 0.34 ± 0.04 (DG) | 35.7 ± 4.85 (CA3) 26.19 ± 8.41 (DG) | Hypo-osmotic stimulus | Gabazine (SR95531) | |||
DHPG, mGluR I agonist; baclofen, GABA.
Parameters of tonic excitatory and inhibitory currents in different brain areas.
| Hippocampus | Fellin et al., | −80 ± 23 pA | 98 ± 9 s | BzATP (100 μM), potentiated by 0 Ca2+ | D-AP5 (50–100 μM), OxATP (300 μM), BBG (2–4 μM) | Both were elicited by BzATP, but SICs were unaffected by OxATP or BBG |
| Angulo et al., | 378.9 ± 87.8 pS (spontaneous, inhibited by D-AP5); 377.6 ± 54.9 pA (induced by TBOA, at +40 mV) | 0 Mg2+, TBOA (100 μM) | D-AP5 (50 μM) | Triggered by overlapping mechanisms, appear together | ||
| Jabaudon et al., | 331 ± 60 pA at +40 mV | TBOA (200 μM), MSO (1.5 mM) | D-AP5 (70 μM) | |||
| Le Meur et al., | 50.8 ± 13.4 pA at +40 mV | TBOA (100 μM), TBOA after preincubation with MSO | D-AP5 (50 μM), MK-801 (40 μM), 7-Cl-KYN (10 μM), PPDA (0.1 μM), NVP-AAM077 (0.1 μM) | |||
| Papouin et al., | 26.8 ± 3.1 pA at +40 mV (inhibited by D-AP5) | D-AP5 (50 μM), reduced by Ro25-6981 (2 μM) and BsGO | ||||
| Spinal dorsal horn | Nie et al., | −75.5±11.25 pA at −70 mV | TBOA (100 μM) | Both triggered by TBOA, appear together | ||
| Supraoptic nucleus | Fleming et al., | 31.8 ± 4.8 pA at +40 mV; −7.4±1.3 pA at −70 mV | Dihydrokainate (300 μM), TBOA (100 μM), α-AA (2 mM) | Kynurenic acid (2 mM), ifenprodil (10 μM), D-AP5 (100 μM), memantine (30 μM) | ||
| Cerebellum, Purkinje-cells | Sasaki et al., | Optogenetic stimulation of Bergmann glia; TBOA (100 μM) | GYKI 53655 (100 μM), NBQX (10 μM), DIDS (1 mM) | |||
| Beppu et al., | Optogenetic stimulation of Bergmann glia; oxygen and glucose deprivation | GYKI 53655 (100 μM), DIDS (1 mM) | ||||
| Pedunculopontine nucleus | Kõszeghy et al., | −24.5±4.4 pA at −60 mV | ACEA (5 μM) | Only tonic depolarization was investigated; thapsigargin (1 μM), LY 341495 (10 μM) | ||
| Olfactory bulb (mitral, external tufted cells) | Belluzzi et al., | Approx. −300 pA at −90 mV, +200 pA at −60 mV (10 mM taurine); biphasic at −60 mV | 1.98 ± 0.23 s (10–90% rise time) | Taurine (2.5–10 mM), GABA (rapid decay; 200 μM) | Bicuculline (10 μM), picrotoxin (10 μM) | |
| Hypothalamic paraventricular nucleus | Park et al., | 32.79 ± 5.04 pA (300 μM nipecotic acid) | Nipecotic acid (100, 300 μM); β-alanine (100 μM) | Bicuculline (20 μM; if elicited by nipecotic acid) bicuculline (20 μM) and strychnine (10 μM), if elicited by β-alanine | ||
| 89.25 ± 22.66 pA (100 μM β-alanine) | ||||||
| Inward current with symmetrical Cl− concentrations | ||||||
| Cerebellar granule cells | Lee et al., | 35.7 ± 4.1 pA at -60 mV with symmetrical Cl− concentrations, blocked with SR95531 | SR95531 (10 μM); NPPB (50 μM), NFA, DIDS (100 μM) | |||
| Neocortex | Lalo et al., | 39.9 ± 8.3 pA at −80 mV, with symmetrical Cl− concentrations, blocked by bicuculline | Impairment of SNARE in astrocytes (dn-SNARE) | Bicuculline (50 μM), TFLLR (10 μM), TFLLR + PPADS (10 μM) | ||
| Pedunculopontine nucleus | Kõszeghy et al., | 19 ± 1.9 pA at −60 mV | ACEA (5 μM) | Tonic hyperpolarization was blocked by MPEP (10 μM) + CPCCOEt (100 μM), thapsigargin (1 μM) | ||
| Hypoglossal motoneurons | Gomeza et al., | 62.2 pA at −70 mV with symmetrical Cl− concentrations | Disruption of GlyT1 gene | Strychnine (10 μM) | ||
| Spinal cord, lamina X neurons | Bradaïa et al., | −20 to −50 pA at −60 mV, with symmetrical Cl− concentrations | ORG24598 (10 μM); also potentiated by ORG25543 (10 μM) | Strychnine (1 μM) | ||
BzATP, purinergic receptor agonist; D-AP5, NMDA receptor antagonist; OxATP, P2X.